Zymo Research Corp. Launches ‘Give Back to Science’ Campaign

Reaching out to scientists around the world to provide valuable scientific resources IRVINE, Calif., (Nov. 19, 2018) — Zymo Research understands that science may help solve some of the world’s most pressing problems, especially in developing countries. Unfortunately, many scientists in emergent nations face barriers to accessing hands-on education, laboratory equipment, and supplies. That’s why Zymo... Read more

Two Pore Guys Receives $2.8M Grant to Develop Sensitive, Low-Cost Molecular Diagnostic Tests for Tuberculosis

Goal of Bill & Melinda Gates Foundation Grant Is to Improve TB Care in Resource-Poor Settings SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys, Inc. (2PG) today announced that the company has received a $2.8 million grant from the Bill & Melinda Gates Foundation to develop sensitive, low-cost molecular diagnostic tests for tuberculosis (TB) using its solid-state nanopore technology.... Read more

Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health

Sunnyvale, Nov. 05, 2018 (GLOBE NEWSWIRE) — Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter Health. The company is providing its proprietary microarray-based finger stick allergy testing services to Sutter Health via doctors in the Sutter Health-affiliated Palo Alto Medical Foundation. Sutter Health,... Read more

EDQM laboratory: new NMR accreditation strengthens characterisation capacity for reference standards

16 NOVEMBER 2018   STRASBOURG, FRANCE The expertise of the EDQM laboratory has recently been confirmed by an ISO 17025 accreditation for Nuclear Magnetic Resonance spectroscopy (NMR) and quantitative Nuclear Magnetic Resonance spectroscopy (qNMR). These modern and state of the art techniques further expand the technical competence of the EDQM laboratory to characterise the official reference standards of the European Pharmacopoeia... Read more

Halma acquires innovative British radar surveillance and safety solutions company

16 November 2018 Halma has acquired Navtech Radar Ltd in a move that will add new capabilities to our Infrastructure Safety sector. Navtech Radar is a provider of innovative radar surveillance and safety solutions for use in highway monitoring, perimeter security and industrial applications. Based in Wantage, UK, Navtech combines radar, cameras and software to improve... Read more

Sartorius Stedim Biotech and Lonza Modify Relationship for Supply of Cell Culture Media

Sartorius Stedim Biotech will continue to offer Lonza media and buffer products but under a non-exclusive agreement Lonza selects Sartorius Stedim Biotech as preferred supplier for equipment and consumables Aubagne, November 15, 2018 – Sartorius Stedim Biotech (SSB), a leading international supplier of the biopharmaceutical industry, and Lonza announced today that they have modified their current... Read more

Dynex Technologies Receives CFDA Approval to Supply AGILITY Automated ELISA Processing System to China

Company’s portfolio approval demonstrates dedication to clinical labs in the Asia-Pacific region November 15, 2018 08:14 AM Pacific Standard Time CHANTILLY, Va.–(BUSINESS WIRE)–Dynex® Technologies, Inc., announced today that it received Chinese Food and Drug Administration (CFDA) approval to market its DYNEX AGILITY® instrument and software for quantitative immunoassay measurements of analytes, including proteins and microbiological specimens. “With... Read more

Pressure BioSciences Achieves Second Major Milestone in the Development of Its Ultra Shear Technology Platform

November 15, 2018 Company Announces Successful Development of Proprietary Method for High Quality, Water Soluble Oils, Opening Major New Opportunities in Multiple Markets; Initial Focus to be in the CBD Oil and Cosmetics Markets SOUTH EASTON, MA / ACCESSWIRE / November 15, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in... Read more

New Product Introduction: iCELLis® 500+ Bioreactor

November 15, 2018 The new and improved iCELLis 500+ bioreactor system will simplify large scale cGMP production of virus for vaccines or gene therapy. New features provide enhanced robust control, reliability, and sustainability of high-density adherent cell growth in an automated format.   Boasting a new stainless steel frame and temperature control unit (TCU), the... Read more